{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T18:26:33Z","timestamp":1783016793092,"version":"3.54.6"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The prevalence and clinically associated factors of hyperuricemia (HUA) have been widely studied in the general population but rarely in patients with bipolar disorder (BPD) co-morbid with HUA. This study attempted to investigate the prevalence of HUA in BPD patients and analyze the associated correlates of HUA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>In this study, 182 outpatients with BPD and 182 healthy controls participated. The demographic and clinical information were collected. The body weight, height, waist circumference (WC), hip circumference (HC), and blood pressure (BP) were measured. The levels of serum uric acid (UA), triglyceride (TG), high-density lipoprotein (HDL-C), and fasting blood glucose (FBG) were also determined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>BPD patients had a significantly higher prevalence of HUA (40.7%) compared to healthy controls (30.2%) (\u03c7<jats:sup>2<\/jats:sup> = 4.335, <jats:italic>P<\/jats:italic> = 0.037). The systolic blood pressure (SBP), pulse pressure (PP), FBG, UA, and body mass index (BMI) were higher in the BPD group compared with those in the control group, while the diastolic blood pressure (DBP) and HDL-C level were lower (<jats:italic>P<\/jats:italic> &amp;lt; 0.05) in BPD patients. The prevalence of HUA was higher in BPD patients who used antipsychotics combined with mood stabilizers than that in BPD subjects receiving the mood stabilizers alone (<jats:italic>P<\/jats:italic> &amp;lt; 0.001). The prevalence of HUA and increased serum UA levels were higher in the manic group (62.1%) than in the depressive (34.3%) or euthymia group (17.0%) (<jats:italic>P<\/jats:italic> &amp;lt; 0.001). Additionally, the severity of mania was positively correlated with the UA level (<jats:italic>r<\/jats:italic> = 0.410, <jats:italic>P<\/jats:italic> &amp;lt; 0.001). There were significant differences in terms of MetS (29.7% vs. 14.8%), BMI, HC, WC, TG, and HDL-C between the HUA and the non-HUA groups (<jats:italic>P<\/jats:italic> &amp;lt; 0.05). The unconditional logistic regression analysis revealed that high BMI (OR = 1.210; 95%CI: 1.100\u20131.331) and high TG level (OR = 1.652; 95%CI: 1.058\u20132.580) were the major risk factorids for HUA in BPD patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our study suggests that patients with BPD are prone to metabolic diseases such as HUA. Higher serum levels of TG and high BMI could be associated with HUA development. Clinicians need to regularly monitor and evaluate BPD patients for their serum UA levels, especially for BPD patients with manic\/hypomanic episodes and\/or under the treatment of antipsychotics combined with mood stabilizers.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnins.2022.998747","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T10:36:33Z","timestamp":1663324593000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["The prevalence and associated clinical correlates of hyperuricemia in patients with bipolar disorder"],"prefix":"10.3389","volume":"16","author":[{"given":"Shuyun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zebin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zezhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1100\/tsw.2003.90","article-title":"Uric acid or 1-methyl uric acid in the urinary bladder increases serum glucose, insulin, true triglyceride, and total cholesterol levels in Wistar rats.","volume":"3","author":"Balasubramanian","year":"2003","journal-title":"ScientificWorldJournal"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32548-0","article-title":"Bipolar disorder.","volume":"392","author":"Barnett","year":"2018","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/14737159.2017.1270757","article-title":"Update on bipolar disorder biomarker candidates: what about uric acid\/adenosine hypothesis.","volume":"17","author":"Bartoli","year":"","journal-title":"Expert Rev. Mol. Diagn."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.comppsych.2016.09.011","article-title":"Purinergic system dysfunctions in subjects with bipolar disorder: A comparative cross-sectional study.","volume":"73","author":"Bartoli","year":"","journal-title":"Compr. Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jpsychires.2016.07.007","article-title":"Uric acid levels in subjects with bipolar disorder: A comparative meta-analysis.","volume":"81","author":"Bartoli","year":"2016","journal-title":"J. Psychiatr. Res."},{"key":"B6","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/s41366-019-0487-9","article-title":"The causal role of elevated uric acid and waist circumference on the risk of metabolic syndrome components","volume":"44","author":"Biradar","year":"2020","journal-title":"Int. J. Obes. (Lond.)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11906-010-0098-2","article-title":"Uric acid as a factor in the metabolic syndrome.","volume":"12","author":"Borges","year":"2010","journal-title":"Curr. Hypertens. Rep."},{"key":"B8","doi-asserted-by":"crossref","DOI":"10.1017\/S2045796021000305","article-title":"Excess mortality and lifeyears lost in people with bipolar disorder: An 11-year populationbased cohort study","volume":"30","author":"Chan","year":"2021","journal-title":"Epidemiol. Psychiatr. Sci."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00767","article-title":"Patients with drug-naive bipolar disorder in remission after 8 weeks of treatment had decreased serum uric acid concentrations.","volume":"10","author":"Chen","year":"2019","journal-title":"Front. Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-018-1952-z","article-title":"Association between hyperuricemia and metabolic syndrome in patients suffering from bipolar disorder.","volume":"18","author":"Chen","year":"2018","journal-title":"BMC Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/wps.20420","article-title":"Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls.","volume":"16","author":"Correll","year":"2017","journal-title":"World Psychiatry"},{"key":"B12","first-page":"195","article-title":"Evaluation of plasma antioxidant levels during different phases of illness in adult patients with bipolar disorder.","volume":"22","author":"De Berardis","year":"2008","journal-title":"J Biol Regul Homeost Agents."},{"key":"B13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/j.2051-5545.2011.tb00014.x","article-title":"Physical illness in patients with severe mental disorders, I. Prevalence, impact of medications and disparities in health care.","volume":"10","author":"De Hert","year":"2011","journal-title":"World Psychiatry"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1038\/oby.2012.47","article-title":"BMI predicts emotion-driven impulsivity and cognitive inflexibility in adolescents with excess weight.","volume":"20","author":"Delgado-Rico","year":"2012","journal-title":"Obesity"},{"key":"B15","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1399-5618.2009.00664.x","article-title":"Tobacco smoking behaviors in bipolar disorder: a comparison of the general population, schizophrenia, and major depression.","volume":"11","author":"Diaz","year":"2009","journal-title":"Bipolar Disord."},{"key":"B16","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1093\/ajh\/hpt168","article-title":"Is pulse pressure an independent risk factor for incident acute coronary heart disease events? The REGARDS study.","volume":"27","author":"Glasser","year":"2014","journal-title":"Am. J. Hypertens."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.2174\/1381612811319130011","article-title":"Chronic hyperuricemia, uric acid deposit and cardiovascular risk.","volume":"19","author":"Grassi","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"B18","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4103\/0253-7176.101767","article-title":"Metabolic syndrome in bipolar disorders.","volume":"34","author":"Grover","year":"2012","journal-title":"Indian J. Psychol. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1176\/appi.ajp.157.6.975","article-title":"Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study.","volume":"157","author":"Henderson","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"B20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/bdi.12980","article-title":"Oxidative stress parameters and antioxidants in patients with bipolar disorder: Results from a meta-analysis comparing patients, including stratification by polarity and euthymic status, with healthy controls.","volume":"23","author":"Jim\u00e9nez-Fern\u00e1ndez","year":"2021","journal-title":"Bipolar Disord."},{"key":"B21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jad.2014.04.053","article-title":"Uric acid levels may be a biological marker for the differentiation of unipolar and bipolar disorder: the role of affective temperament.","volume":"165","author":"Kesebir","year":"2014","journal-title":"J. Affect. Disord."},{"key":"B22","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jad.2015.03.027","article-title":"Causes of decreased life expectancy over the life span in bipolar disorder.","volume":"180","author":"Kessing","year":"2015","journal-title":"J. Affect. Disord."},{"key":"B23","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/S0140-6736(04)16669-5","article-title":"Alcohol intake, serum uric acid concentrations, and risk of gout.","volume":"364","author":"Liberopoulos","year":"2004","journal-title":"Lancet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"11528","DOI":"10.3390\/ijerph120911528","article-title":"Serum Adiponectin and Leptin Concentrations in Relation to Body Fat Distribution, Hematological Indices and Lipid Profile in Humans.","volume":"12","author":"Lubkowska","year":"2015","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B25","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1097\/JCP.0b013e318268391d","article-title":"Purinergic system in the treatment of bipolar disorder: uric acid levels as a screening test in mania.","volume":"32","author":"Machado-Vieira","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1054\/mehy.2001.1543","article-title":"Purinergic dysfunction in mania: an integrative model.","volume":"58","author":"Machado-Vieira","year":"2002","journal-title":"Med. Hypotheses"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.4088\/JCP.v69n0806","article-title":"A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the Purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania.","volume":"69","author":"Machado-Vieira","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"B28","doi-asserted-by":"publisher","first-page":"577","DOI":"10.12740\/PP\/97335","article-title":"Disturbances of purinergic system in affective disorders and schizophrenia.","volume":"53","author":"Malewska-Kasprzak","year":"2019","journal-title":"Psychiatr. Pol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"634","DOI":"10.4088\/JCP.v65n0507","article-title":"Are mood disorders and obesity related? A review for the mental health professional.","volume":"65","author":"McElroy","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"B30","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative.","volume":"68","author":"Merikangas","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"B31","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1177\/1742395310395959","article-title":"\u2018It\u2019s something that I manage but it is not who I am\u2019: reflections on internalized stigma in individuals with bipolar disorder.","volume":"7","author":"Michalak","year":"2011","journal-title":"Chronic Illn."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-014-0499-z","article-title":"Excess mortality in bipolar disorders.","volume":"16","author":"Miller","year":"2014","journal-title":"Curr. Psychiatry Rep."},{"key":"B33","first-page":"235","article-title":"[Chinese multi-disciplinary consensus on the diagnosis and treatment of hyperuricemia and its related diseases].","volume":"56","year":"2017","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"B34","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.smrv.2014.06.006","article-title":"Sleep-wake disturbance in interepisode bipolar disorder and high-risk individuals: a systematic review and meta-analysis.","volume":"20","author":"Ng","year":"2015","journal-title":"Sleep Med. Rev."},{"key":"B35","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.ntt.2011.05.005","article-title":"Inhibitory effect of lithium on nucleotide hydrolysis and acetylcholinesterase activity in zebrafish (Danio rerio) brain.","volume":"33","author":"Oliveira Rda","year":"2011","journal-title":"Neurotoxicol. Teratol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.pnpbp.2014.10.016","article-title":"Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics.","volume":"57","author":"Ortiz","year":"2015","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B37","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ejphar.2014.06.042","article-title":"Lithium: a review of pharmacology, clinical uses, and toxicity.","volume":"740","author":"Oruch","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1124\/pr.58.1.6","article-title":"Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1177\/0269881117722987","article-title":"Mechanisms underlying metabolic disturbances associated with psychosis and antipsychotic drug treatment.","volume":"31","author":"Reynolds","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.007621","article-title":"Relationship of arterial stiffness index and pulse pressure with cardiovascular disease and mortality.","volume":"7","author":"Said","year":"2018","journal-title":"J. Am. Heart. Assoc."},{"key":"B41","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.pnpbp.2010.02.027","article-title":"Increased uric acid levels in drug-na\u00efve subjects with bipolar disorder during a first manic episode.","volume":"34","author":"Salvadore","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14855","article-title":"Hyperuricemia and cardiovascular risk.","volume":"13","author":"Shahin","year":"2021","journal-title":"Cureus"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0254590","article-title":"Association between serum uric acid and cardiovascular disease risk factors in adolescents in America: 2001-2018.","volume":"16","author":"Shi","year":"2021","journal-title":"PLoS One"},{"key":"B44","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.biopsych.2013.02.024","article-title":"Impulsivity is associated with uric acid: evidence from humans and mice.","volume":"75","author":"Sutin","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1080\/14737159.2016.1248413","article-title":"Update on bipolar disorder biomarker candidates.","volume":"16","author":"Teixeira","year":"2016","journal-title":"Expert Rev. Mol. Diagn."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-017-0688-y","article-title":"Gout and metabolic syndrome: a tangled web.","volume":"19","author":"Thottam","year":"2017","journal-title":"Curr. Rheumatol. Rep."},{"key":"B47","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S2215-0366(15)00505-2","article-title":"Estimating the true global burden of mental illness.","volume":"3","author":"Vigo","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"B48","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1001\/jamapsychiatry.2014.2502","article-title":"Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis.","volume":"72","author":"Walker","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13845","article-title":"The association of serum uric acid with metabolic syndrome and its components-From a single-clinical centre in China.","volume":"75","author":"Xu","year":"2021","journal-title":"Int. J. Clin. Pract."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1210\/en.2011-0004","article-title":"Impaired CNS leptin action is implicated in depression associated with obesity.","volume":"152","author":"Yamada","year":"2011","journal-title":"Endocrinology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jacl.2017.10.009","article-title":"Higher triglyceride level predicts hyperuricemia: A prospective study of 6-year follow-up.","volume":"12","author":"Zhang","year":"2018","journal-title":"J. Clin. Lipidol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jad.2016.05.059","article-title":"The potential association between obesity and bipolar disorder: A meta-analysis.","volume":"202","author":"Zhao","year":"2016","journal-title":"J. Affect. Disord."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2022.998747\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T10:36:41Z","timestamp":1663324601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2022.998747\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":52,"alternative-id":["10.3389\/fnins.2022.998747"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2022.998747","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,16]]},"article-number":"998747"}}